- CRS Publications
- News
News
Authors:
Date:
PRNewswire: October 6, 2016 – WARREN, NJ, U.S.A., BALTIMORE, MD, U.S.A., and MUMBAI, India – Lupin Pharmaceutical Inc., the U.S. subsidiary of pharma major Lupin Limited (collectively Lupin), and MonoSol Rx, a specialty pharmaceutical company, have entered into a strategic licensing agreement…
Authors:
Date:
Business Wire: October 3, 2016 – MIAMI, FL and NEW YORK, NY, U.S.A. – Noven Pharmaceuticals, Inc., today announced the appointment of Ralph Lipp, Ph.D., as the company’s new vice president and chief scientific officer. In this role, Dr. Lipp will lead all research and development efforts for Noven’…
Authors:
Date:
Business Wire: September 26, 2016 – CAMBRIDGE, MA, U.S.A. – Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the company will focus its resources on its proprietary GalXC™ technology platform to advance…
Authors:
Date:
PRNewswire: September 7, 2016 – VANCOUVER, British Columbia, Canada, and WALNUT CREEK, CA, U.S.A. – DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc. (OTCQB: ACXA) (“…
Authors:
Date:
PRNewswire: September 1, 2016 – MISSISSAUGA, Ontario, Canada – Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the company), a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired…
Authors:
Date:
Business Wire: August 31, 2016 – AUSTIN, TX, U.S.A. – Caisson Biotech, LLC, has engaged Pickwick Capital Partners, LLC (member FINRA/SIPC), to assist in the sale of the HEPtune® drug-delivery platform. The proprietary platform centers on the use of a naturally occurring sugar polymer, heparosan,…
